This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of chiral molecules. It serves as a key intermediate in the production of active pharmaceutical ingredients (APIs) that target central nervous system disorders. Its chiral nature makes it valuable for creating enantiomerically pure drugs, which can enhance efficacy and reduce side effects. Additionally, it is employed in the study of receptor-binding activities, aiding in the discovery of novel therapeutic agents for conditions such as anxiety, depression, and neurodegenerative diseases. Its bromine moiety also allows for further functionalization, enabling the development of diverse chemical libraries for drug screening.